Sermorelin is a GHRH analogue studied for stimulating endogenous growth hormone secretion with a favorable safety profile. Physician-reviewed. Prescription required.
Sermorelin is a synthetic analog of GHRH that acts primarily on the pituitary gland to stimulate endogenous growth hormone secretion. Its mechanism is receptor-mediated, working through the natural GH axis.
Unlike exogenous GH, sermorelin works through the body's natural feedback mechanisms, which may offer a more favorable safety profile. It has been studied for GH restoration, body composition, sleep quality, and recovery support. Individual outcomes may differ. This protocol is not intended to diagnose, treat, cure, or prevent any disease.
| Mechanism | Biological Effect |
|---|---|
| GHRH receptor agonism | Stimulates endogenous GH secretion |
| cAMP/PKA signaling | Promotes GH release from somatotrophs |
| Pulsatile GH amplification | Physiologic GH elevation |
| Secondary IGF-1 production | Anabolic effects |
| Reduced side effect profile | Safer than exogenous GH therapy |
Your physician will determine eligibility based on your complete health intake. The following profiles are commonly associated with Sermorelin protocol candidates in clinical practice:
GH Decline
Individuals with age-related GH decline seeking physician-supervised secretagogue therapy.
Body Composition
Individuals pursuing physician-reviewed lean mass support and fat metabolism optimization.
Sleep Quality
Individuals with sleep disruption where GH-mediated sleep architecture support may be clinically relevant.
Recovery Protocol
Athletes or executives managing physical stress where GH-mediated recovery is clinically appropriate.
Determine your candidacy
A physician will review your intake and make eligibility determination within 24–48 hours.
All outcome language below reflects what has been observed in clinical and preclinical settings. Individual outcomes may differ significantly. These are not guarantees.
Dosing is determined individually by your assigned physician. The following represents typical ranges discussed in clinical literature. Do not self-administer or adjust dosing without physician guidance.
Typical Range
200–500 mcg/day
Administration
Subcutaneous injection
Duration
12–24 weeks (physician-determined)
Frequency
Once daily at bedtime (physician-determined)
These ranges are indicative only. Your physician will prescribe the specific dose and schedule appropriate for your clinical profile.
Physician consultation — Virtual intake review and protocol consultation with your assigned NP/MD
Valid prescription — Issued by your attending physician upon protocol approval
Pharmacy-dispensed compound — Dispensed by our licensed 503A compounding pharmacy partner
Follow-up check-in — Physician review at protocol midpoint; reorder pathway established
Your physician will review your complete health history before determining eligibility. The following are commonly reviewed clinical considerations.
Begin your Sermorelin protocol.
Complete your intake. Physician review within 24–48 hours.
Physician-reviewed. Pharmacy-dispensed. Prescription required before any order is fulfilled.
Prescription required. Results may vary. Individual outcomes may differ.
Inject sermorelin 30-60 minutes before sleep to align with your body's natural growth hormone pulse during deep sleep.
Improved sleep quality is often noticed in weeks 1-4. Body composition improvements typically appear at months 2-4. Full results develop over a 6-month cycle.
Sermorelin stimulates your pituitary to produce its own growth hormone naturally. Synthetic HGH bypasses this process. Sermorelin is generally safer, less expensive, and works within your body's feedback system.
Yes. The sermorelin/ipamorelin stack is one of the most popular GH protocols, working via different receptors for a synergistic, stronger GH pulse.